A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study(dagger)

JG Aerts; H. Codrington; N.A.G. Lankheet; S. Burgers; B. Biesma; A.M.C. Dingemans; A.D. Vincent; O. Dalesio; H.J.M. Groen; E.F. Smit

doi:10.1093/annonc/mdt341

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study(dagger)

JG Aerts, H. Codrington, N.A.G. Lankheet, S. Burgers, B. Biesma, A.M.C. Dingemans, A.D. Vincent, O. Dalesio, H.J.M. Groen, E.F. Smit

Pulmonary medicine

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	2860-2865
Journal	Annals of Oncology
Volume	24
Issue number	11
DOIs	https://doi.org/10.1093/annonc/mdt341
Publication status	Published - 2013

Access to Document

10.1093/annonc/mdt341

Cite this

Aerts, JG., Codrington, H., Lankheet, N. A. G., Burgers, S., Biesma, B., Dingemans, A. M. C., Vincent, A. D., Dalesio, O., Groen, H. J. M., & Smit, E. F. (2013). A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study(dagger). Annals of Oncology, 24(11), 2860-2865. https://doi.org/10.1093/annonc/mdt341

Aerts, JG ; Codrington, H. ; Lankheet, N.A.G. ; Burgers, S. ; Biesma, B. ; Dingemans, A.M.C. ; Vincent, A.D. ; Dalesio, O. ; Groen, H.J.M. ; Smit, E.F. / A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study(dagger). In: Annals of Oncology. 2013 ; Vol. 24, No. 11. pp. 2860-2865.

@article{5635182ef2fa4f27aa7f0de831079108,

title = "A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study(dagger)",

author = "JG Aerts and H. Codrington and N.A.G. Lankheet and S. Burgers and B. Biesma and A.M.C. Dingemans and A.D. Vincent and O. Dalesio and H.J.M. Groen and E.F. Smit",

year = "2013",

doi = "10.1093/annonc/mdt341",

language = "Undefined/Unknown",

volume = "24",

pages = "2860--2865",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "11",

}

Aerts, JG, Codrington, H, Lankheet, NAG, Burgers, S, Biesma, B, Dingemans, AMC, Vincent, AD, Dalesio, O, Groen, HJM & Smit, EF 2013, 'A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study(dagger)', Annals of Oncology, vol. 24, no. 11, pp. 2860-2865. https://doi.org/10.1093/annonc/mdt341

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study(dagger). / Aerts, JG; Codrington, H.; Lankheet, N.A.G.; Burgers, S.; Biesma, B.; Dingemans, A.M.C.; Vincent, A.D.; Dalesio, O.; Groen, H.J.M.; Smit, E.F.

In: Annals of Oncology, Vol. 24, No. 11, 2013, p. 2860-2865.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study(dagger)

AU - Aerts, JG

AU - Codrington, H.

AU - Lankheet, N.A.G.

AU - Burgers, S.

AU - Biesma, B.

AU - Dingemans, A.M.C.

AU - Vincent, A.D.

AU - Dalesio, O.

AU - Groen, H.J.M.

AU - Smit, E.F.

PY - 2013

Y1 - 2013

U2 - 10.1093/annonc/mdt341

DO - 10.1093/annonc/mdt341

M3 - Article

C2 - 23986090

VL - 24

SP - 2860

EP - 2865

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 11

ER -